Italia markets closed

BMY May 2024 42.000 put

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
0,18000,0000 (0,00%)
In data: 02:28PM EDT. Mercato aperto.
Schermo intero
Chiusura precedente0,1800
Aperto0,2300
Denaro0,0700
Lettera0,1100
Prezzo d'esercizio42,00
Scadenza2024-05-31
Min-Max giorno0,1800 - 0,2300
Contratto - Min-MaxN/D
Volume27
Open Interest253
  • GlobeNewswire

    Arbutus Appoints Two New Executives

    Karen Sims, MD, PhD Promoted to Chief Medical Officer Christopher Naftzger Appointed as General Counsel and Chief Compliance Officer WARMINSTER, Pa., July 10, 2023 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop novel therapeutics that target specific viral diseases, today announced the appointment of Dr. Karen Sims as Chief Medical Officer and Mr. Chri